The global preimplantation genetic testing market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include growing occurrences of genetic diseases, rising delayed parenthood and extensive development in technology are fueling the growth of the market. Preimplantation genetic testing (PGT) is a prenatal genetic diagnosis where abnormal embryos are detected, thereby allowing the transfer of genetically normal embryos in an early stage. It enhances the mother's likelihood of giving birth to a child without any inherited diseases. The other factors supporting the market’s growth are the rise in R&D activities, increasing favorable government funding, the rising advent of medical knowledge and growth of technologically advanced genetic devices, rising infertility issues, the increasing awareness among patients about genetic disorders, growing adoption of inorganic growth strategies, high demand of in vitro fertilization treatments, and rising rates in birth defects.
Emerging Delayed Parenthood Foster the Market Growth
Over the past few years, a rise in the number of cases where couples are opting for late pregnancies is driving the growth of the market. The growing maternal age across the world is causing a high risk of chromosomal abnormalities and other various pregnancy complications such as miscarriages. For instance, in America, the standard age of first-time mothers changed from 21 to 26, while for fathers, it’s grown from 27 to 31. Apart from America, the standard age for first pregnancy is 31 in other developed nations.
Growing Rate of Infertility to Support Market Growth
The rising infertility rate around the world is fueling the growth of the market. This is attributed to the rising health problem associated with hormones, poor nutrition, consumption of tobacco, smoking, and alcohol, and increase in stress levels. Owing to the infertility issue among men and women surging, the number of couples opting for IVF is also rising, which, in turn, is bolstering the growth of the market. According to WHO, infertility is a worldwide health problem affecting millions of people of reproductive age. As per the WHO data, between 48 million couples and 186 million entities have infertility worldwide.
Increasing Incidences of Genetic Diseases and Increasing Awareness of Genetic Testing
The rising prevalence of diseases caused by mitochondrial, single-gene, and other gene-related disorders has enhanced people’s interest in preimplantation diagnostic and screening methods. According to the state's Department of Health, in Florida, about 1 in 28 infants is born with a congenital impairment. Therefore, preimplantation genetic testing helps to know the possibility of a person carrying forward genetic diseases to their offspring. Furthermore, there is an increase in awareness for genetic testing due to rising instances of genetic diseases and the prevention of genetic diseases which is bolstering the growth of the market. The growing awareness about the advantages of early diagnosis for genetic diseases is causing a high demand for preimplantation genetic testing. Expectant and parental populations are being educated by doctors to ensure healthy babies.
Market Segmentation
The global preimplantation genetic testing market is segmented into components, technology, application, end-user, and company. Based on components, the market is divided into reagents & consumables, kits, and services. Based on technology, the market is divided into next-generation sequencing (NGS), polymerase chain reaction (PCR), in-situ hybridization, and microarray. Based on application, the market is divided into single gene disorders, aneuploidy, structural chromosomal abnormalities, and others. Based on end users, the market is divided into diagnostic centers, research center, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to rising incidences of genetic disorders in the country.
Market Players
Illumina, Inc., PerkinElmer, Inc., Thermo Fischer Scientific, Inc., Natera, Inc., Abbott Laboratories, Inc., Agilent Technologies, Inc., Invitae Corporation, Myriad Genetics, Inc., MedGenome Labs Ltd., Fulgent Genetics, Inc. are some of the leading companies operating in the market.
Report Scope:
In this report, global preimplantation genetic testing market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:
- Preimplantation Genetic Testing Market, By Component:
- Reagents & Consumables
- Kits
- Services
- Preimplantation Genetic Testing Market, By technology:
- Next-Generation Sequencing
- Polymerase Chain Reaction
- In Situ Hybridization
- Microarray
- Preimplantation Genetic Testing Market, By Application:
- Single Gene Disorder
- Aneuploidy
- Structural Chromosomal Abnormalities
- Others
- Preimplantation Genetic Testing Market, By End User:
- Diagnostic Center
- Research Center
- Others
- Preimplantation Genetic Testing Market, By Region:
- North America
- United States
- Canada
- Mexico
- Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
- Europe & CIS
- Germany
- France
- United Kingdom
- Spain
- Italy
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- Turkey
- Egypt
Company Profiles: Detailed analysis of the major companies present in Global Preimplantation Genetic Testing Market
Company Information
- Detailed analysis and profiling of additional market players (up to five).
- 1. Product Overview
- 2. Research Methodology
- 3. Executive Summary
- 4. Impact of COVID-19 on Global Preimplantation Genetic Testing Market
- 5. Voice of Customer
- 6. Global Preimplantation Genetic Testing Market Outlook
- 6.1. Market Size & Forecast
- 6.1.1. By Value
- 6.2. Market Share & Forecast
- 6.2.1. By Component (Reagents & Consumables, Kits, Services)
- 6.2.2. By Technology (Next Generation Sequencing, Polymerase Chain Reaction, In Situ Hybridization, Microarray)
- 6.2.3. By Application (Single Gene Disorder, Aneuploidy, Structural Chromosomal Abnormalities, Others)
- 6.2.4. By End User (Diagnostic Center, Research Center, Others)
- 6.2.5. By Company (2021)
- 6.2.6. By Region
- 6.3. Market Map
- 7. North America Preimplantation Genetic Testing Market Outlook
- 7.1. Market Size & Forecast
- 7.1.1. By Value
- 7.2. Market Share & Forecast
- 7.2.1. By Component
- 7.2.2. By Technology
- 7.2.3. By Application
- 7.2.4. By End User
- 7.2.5. By Country
- 7.3. North America: Country Analysis
- 7.3.1. United States Preimplantation Genetic Testing Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.1.1. By Value
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Component
- 7.3.1.2.2. By Technology
- 7.3.1.2.3. By Application
- 7.3.1.2.4. By End User
- 7.3.2. Canada Preimplantation Genetic Testing Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.1.1. By Value
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Component
- 7.3.2.2.2. By Technology
- 7.3.2.2.3. By Application
- 7.3.2.2.4. By End User
- 7.3.3. Mexico Preimplantation Genetic Testing Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.1.1. By Value
- 7.3.3.2. Market Share & Forecast
- 7.3.3.2.1. By Component
- 7.3.3.2.2. By Technology
- 7.3.3.2.3. By Application
- 7.3.3.2.4. By End User
- 8. Europe Preimplantation Genetic Testing Market Outlook
- 8.1. Market Size & Forecast
- 8.1.1. By Value
- 8.2. Market Share & Forecast
- 8.2.1. By Component
- 8.2.2. By Technology
- 8.2.3. By Application
- 8.2.4. By End User
- 8.2.5. By Country
- 8.3. Europe: Country Analysis
- 8.3.1. France Preimplantation Genetic Testing Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.1.1. By Value
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Component
- 8.3.1.2.2. By Technology
- 8.3.1.2.3. By Application
- 8.3.1.2.4. By End User
- 8.3.2. Germany Preimplantation Genetic Testing Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.1.1. By Value
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Component
- 8.3.2.2.2. By Technology
- 8.3.2.2.3. By Application
- 8.3.2.2.4. By End User
- 8.3.3. United Kingdom Preimplantation Genetic Testing Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.1.1. By Value
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Component
- 8.3.3.2.2. By Technology
- 8.3.3.2.3. By Application
- 8.3.3.2.4. By End User
- 8.3.4. Italy Preimplantation Genetic Testing Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.1.1. By Value
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Component
- 8.3.4.2.2. By Technology
- 8.3.4.2.3. By Application
- 8.3.4.2.4. By End User
- 8.3.5. Spain Preimplantation Genetic Testing Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.1.1. By Value
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Component
- 8.3.5.2.2. By Technology
- 8.3.5.2.3. By Application
- 8.3.5.2.4. By End User
- 9. Asia-Pacific Preimplantation Genetic Testing Market Outlook
- 9.1. Market Size & Forecast
- 9.1.1. By Value
- 9.2. Market Share & Forecast
- 9.2.1. By Component
- 9.2.2. By Technology
- 9.2.3. By Application
- 9.2.4. By End User
- 9.2.5. By Country
- 9.3. Asia-Pacific: Country Analysis
- 9.3.1. China Preimplantation Genetic Testing Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.1.1. By Value
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Component
- 9.3.1.2.2. By Technology
- 9.3.1.2.3. By Application
- 9.3.1.2.4. By End User
- 9.3.2. India Preimplantation Genetic Testing Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.1.1. By Value
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Component
- 9.3.2.2.2. By Technology
- 9.3.2.2.3. By Application
- 9.3.2.2.4. By End User
- 9.3.3. Japan Preimplantation Genetic Testing Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.1.1. By Value
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Component
- 9.3.3.2.2. By Technology
- 9.3.3.2.3. By Application
- 9.3.3.2.4. By End User
- 9.3.4. South Korea Preimplantation Genetic Testing Market Outlook
- 9.3.4.1. Market Size & Forecast
- 9.3.4.1.1. By Value
- 9.3.4.2. Market Share & Forecast
- 9.3.4.2.1. By Component
- 9.3.4.2.2. By Technology
- 9.3.4.2.3. By Application
- 9.3.4.2.4. By End User
- 9.3.5. Australia Preimplantation Genetic Testing Market Outlook
- 9.3.5.1. Market Size & Forecast
- 9.3.5.1.1. By Value
- 9.3.5.2. Market Share & Forecast
- 9.3.5.2.1. By Component
- 9.3.5.2.2. By Technology
- 9.3.5.2.3. By Application
- 9.3.5.2.4. By End User
- 10. South America Preimplantation Genetic Testing Market Outlook
- 10.1. Market Size & Forecast
- 10.1.1. By Value
- 10.2. Market Share & Forecast
- 10.2.1. By Component
- 10.2.2. By Technology
- 10.2.3. By Application
- 10.2.4. By End User
- 10.2.5. By Country
- 10.3. South America: Country Analysis
- 10.3.1. Brazil Preimplantation Genetic Testing Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.1.1. By Value
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Component
- 10.3.1.2.2. By Technology
- 10.3.1.2.3. By Application
- 10.3.1.2.4. By End User
- 10.3.2. Argentina Preimplantation Genetic Testing Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.1.1. By Value
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Component
- 10.3.2.2.2. By Technology
- 10.3.2.2.3. By Application
- 10.3.2.2.4. By End User
- 10.3.3. Colombia Preimplantation Genetic Testing Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.1.1. By Value
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Component
- 10.3.3.2.2. By Technology
- 10.3.3.2.3. By Application
- 10.3.3.2.4. By End User
- 11. Middle East and Africa Preimplantation Genetic Testing Market Outlook
- 11.1. Market Size & Forecast
- 11.1.1. By Value
- 11.2. Market Share & Forecast
- 11.2.1. By Component
- 11.2.2. By Technology
- 11.2.3. By Application
- 11.2.4. By End User
- 11.2.5. By Country
- 11.3. MEA: Country Analysis
- 11.3.1. South Africa Preimplantation Genetic Testing Market Outlook
- 11.3.1.1. Market Size & Forecast
- 11.3.1.1.1. By Value
- 11.3.1.2. Market Share & Forecast
- 11.3.1.2.1. By Component
- 11.3.1.2.2. By Technology
- 11.3.1.2.3. By Application
- 11.3.1.2.4. By End User
- 11.3.2. Saudi Arabia Preimplantation Genetic Testing Market Outlook
- 11.3.2.1. Market Size & Forecast
- 11.3.2.1.1. By Value
- 11.3.2.2. Market Share & Forecast
- 11.3.2.2.1. By Component
- 11.3.2.2.2. By Technology
- 11.3.2.2.3. By Application
- 11.3.2.2.4. By End User
- 11.3.3. UAE Preimplantation Genetic Testing Market Outlook
- 11.3.3.1. Market Size & Forecast
- 11.3.3.1.1. By Value
- 11.3.3.2. Market Share & Forecast
- 11.3.3.2.1. By Component
- 11.3.3.2.2. By Technology
- 11.3.3.2.3. By Application
- 11.3.3.2.4. By End User
- 11.3.4. Turkey Preimplantation Genetic Testing Market Outlook
- 11.3.4.1. Market Size & Forecast
- 11.3.4.1.1. By Value
- 11.3.4.2. Market Share & Forecast
- 11.3.4.2.1. By Component
- 11.3.4.2.2. By Technology
- 11.3.4.2.3. By Application
- 11.3.4.2.4. By End User
- 11.3.5. Egypt Preimplantation Genetic Testing Market Outlook
- 11.3.5.1. Market Size & Forecast
- 11.3.5.1.1. By Value
- 11.3.5.2. Market Share & Forecast
- 11.3.5.2.1. By Component
- 11.3.5.2.2. By Technology
- 11.3.5.2.3. By Application
- 11.3.5.2.4. By End User
- 12. Market Dynamics
- 12.1. Drivers
- 12.2. Challenges
- 13. Market Trends & Developments
- 14. Competitive Landscape
- 14.1. Illumina, Inc.
- 14.2. PerkinElmer, Inc.
- 14.3. Thermo Fischer Scientific, Inc.
- 14.4. Natera, Inc.
- 14.5. Abbott Laboratories, Inc.
- 14.6. Agilent Technologies, Inc.
- 14.7. Invitae Corporation
- 14.8. Myriad Genetics, Inc.
- 14.9. MedGenome Labs Ltd.
- 14.10. Fulgent Genetics, Inc.
- 15. Strategic Recommendations
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook